GO:0002263 cell activation involved in immune response: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002263 describes the process by which a cell changes its morphology or behavior after exposure to an activating factor, thereby initiating or perpetuating an immune response.
• It covers innate and adaptive immune cell activation, including Toll-like receptor signalling, cytokine-driven differentiation, and effector functions such as neutrophil extracellular trap formation [1,3].
• Key molecular drivers include TLR signalling components, STING, STAT4, STAT6, and autophagy regulators that tune the intensity and duration of activation [1,6,7].
• Dysregulated cell activation involved in immune response contributes to chronic viral hepatitis, hypertension-associated inflammation, autoimmunity, and cancer [2,5,6].
• Single-cell RNA dynamics and in vivo models such as Salmonella infection reveal how activation states evolve in real time.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to causally link specific genes to activation phenotypes [1,6,8].
Description
Cell activation involved in immune response (GO:0002263) is a biological process that captures the moment a cell transitions from a resting to an activated state after encountering an activating factor, such as a cellular or soluble ligand. This process is fundamental to both innate and adaptive immunity because it converts receptor engagement into effector functions that eliminate pathogens and shape long-term protection [1,2]. The term encompasses changes in morphology, gene expression, metabolism, and behavior that collectively initiate or perpetuate an immune response.
cell activation involved in immune response At A Glance
| GO ID | GO:0002263 |
|---|---|
| GO term | cell activation involved in immune response |
| Ontology | biological_process |
| Synonym | cell activation during immune response |
| Major function | Conversion of activating signals into immune effector functions |
| Definition source | QuickGO |
| Related processes | Toll-like receptor signalling, cytokine signalling, autophagy, neutrophil extracellular trap formation |
| Representative cell types | Macrophages, neutrophils, dendritic cells, T cells, B cells |
What Is GO:0002263?
According to the QuickGO definition, GO:0002263 is a change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response. In practice, this means that a cell receives a signal, integrates it through intracellular pathways, and then alters its state to participate in immune defence [1,3].
Why Is cell activation involved in immune response Important in Cell Biology?
Understanding GO:0002263 is critical because inappropriate or excessive activation of immune cells underlies a broad spectrum of human diseases, from chronic viral infections to autoimmune disorders and hypertension-associated inflammation [2,5,6]. Conversely, insufficient activation leads to immunodeficiency and failure to control pathogens [1,2]. Defining the molecular checkpoints of this process therefore provides therapeutic targets and biomarkers for immune-mediated diseases [1,6].
• Provides a framework for understanding how innate immune cells sense pathogens through Toll-like receptors.
• Explains how cytokines such as IL-12 and IL-4 drive T helper cell differentiation via STAT4 and STAT6.
• Links autophagy to innate immune tuning through STING-dependent pathways.
• Relevant to chronic hepatitis B virus infection, where innate and adaptive activation determine viral control or persistence.
• Contributes to hypertension-associated inflammation through innate immune activation.
• Underpins neutrophil extracellular trap formation, which further amplifies proinflammatory activation.
• Can be studied at single-cell resolution during infection using scIVNL-seq.
• Offers targets for immunomodulatory therapy in cancer and autoimmunity [1,6].
• Helps interpret plant immunity studies where cell-surface and intracellular receptors mutually potentiate activation.
• Guides CRISPR-based functional screens to identify causal activation genes [1,6,8].
What Happens During cell activation involved in immune response?
Ligand recognition and receptor engagement
In simple terms: An immune cell first detects a danger signal through receptors on its surface or inside the cell.
Activation begins when a cellular or soluble ligand binds to a receptor, such as a Toll-like receptor, triggering conformational changes and recruitment of adaptor proteins. This receptor engagement is the initiating event that defines GO:0002263 and can occur through pathogen-associated molecular patterns or cytokines [1,2].
Intracellular signalling and signal integration
In simple terms: The signal is passed inside the cell through a relay of proteins that amplify and interpret it.
Following receptor engagement, intracellular signalling cascades including TLR pathways and STING-dependent autophagy are activated to integrate the signal [1,7]. These pathways determine the strength, duration, and quality of the subsequent immune response.
Transcriptional reprogramming
In simple terms: The cell changes which genes it turns on or off to become fully activated.
Activation leads to transcriptional changes driven by transcription factors such as STAT4 and STAT6, which shape cellular and humoral immunity. Single-cell RNA dynamics during Salmonella infection illustrate how these transcriptional programmes evolve in vivo.
Effector function and morphological change
In simple terms: The activated cell physically changes and starts doing its job, such as releasing traps or cytokines.
Activated neutrophils can release neutrophil extracellular traps that further activate proinflammatory functions, demonstrating how activation perpetuates the immune response. Morphological changes and effector molecule secretion are hallmarks of the activated state.
Resolution or perpetuation
In simple terms: The response either winds down or continues, depending on the context.
Autophagy and regulatory checkpoints can tune or terminate activation to prevent immunopathology. In chronic infections such as hepatitis B, persistent activation contributes to disease progression.
Key Genes Involved in GO:0002263 cell activation involved in immune response
The following genes and proteins are central to cell activation involved in immune response, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR4 | Toll-like receptor sensing of LPS | Model for innate activation |
| MYD88 | Adaptor in TLR signalling | Knockout studies of activation |
| STING1 | Activates autophagy to tune innate immunity | Links autophagy to activation |
| STAT4 | Drives Th1 differentiation | Autoimmunity and infection models |
| STAT6 | Drives Th2 differentiation | Allergy and asthma models |
| IL12B | Cytokine inducing STAT4 | T cell activation studies |
| IL4 | Cytokine inducing STAT6 | Humoral immunity models |
| NFKB1 | Transcription factor downstream of TLRs | Inflammation models |
| IRF3 | Transcription factor in antiviral activation | Innate immunity studies |
| MAPK1 | Kinase in activation cascades | Signalling studies |
| PIK3CD | PI3K subunit in immune cell activation | Knockout models |
| ATG5 | Autophagy machinery | STING-autophagy axis |
| ATG7 | Autophagy machinery | Autophagy-immune crosstalk |
| PADI4 | Enzyme for NET formation | Neutrophil activation |
| ELANE | Neutrophil serine protease | NET and activation studies |
| MPO | Myeloperoxidase in neutrophils | Oxidative burst models |
| CXCL8 | Chemokine amplifying neutrophil activation | Inflammation models |
How Is cell activation involved in immune response Regulated?
Cell activation involved in immune response is tightly regulated by intracellular checkpoints including autophagy, which can degrade signalling intermediates and dampen activation. Cytokine signalling through STAT4 and STAT6 provides positive and negative feedback that shapes the magnitude of the response. Toll-like receptor signalling is also subject to spatial and temporal regulation to avoid excessive inflammation.
cell activation involved in immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STAT4 | Autoimmunity, inflammation | Knockout and point-mutation models |
| STAT6 | Allergy, asthma | Knock-in reporter models |
| STING1 | Innate immune dysregulation | Autophagy reporter knockout |
| TLR4 | Sepsis, chronic inflammation | Overexpression and knockout |
| PADI4 | NET-associated pathology | Point-mutation models |
Chronic hepatitis B virus infection
In chronic hepatitis B, innate and adaptive immune activation determines whether the virus is controlled or persists, and understanding these activation pathways informs treatment targets.
Hypertension and cardiovascular inflammation
Innate immune activation contributes to hypertension-associated inflammation, linking GO:0002263 to cardiovascular disease.
Autoimmunity and inflammatory disorders
Dysregulated STAT4 and STAT6 signalling skews T helper responses and is implicated in diverse human diseases including autoimmune conditions.
Cancer immunosurveillance
Proper activation of immune cells is required for tumour surveillance, and defects in activation pathways can permit tumour escape.
From cell activation involved in immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a gene required for TLR-induced activation? | CRISPR knockout |
| Does a specific phosphorylation site control activation? | Point-mutation knock-in |
| Where is the protein localized during activation? | Tagged knock-in |
| Does overexpression amplify activation? | Overexpression cell line |
| Which genes regulate activation in vivo? | CRISPR library screening |
| How does activation evolve during infection? | Single-cell RNA dynamics |
How to Study the cell activation involved in immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| scRNA-seq | Transcriptional activation states | In vivo infection models |
| CRISPR KO | Gene requirement for activation | TLR signalling |
| Point mutation | Residue-level function | STAT phosphorylation |
| Autophagy flux | STING-dependent degradation | Innate immune tuning |
| NET assay | Neutrophil activation output | Inflammation |
| Cytokine ELISA | Secreted activation markers | Immune response quantification |
| Flow cytometry | Surface activation markers | Cell activation phenotyping |
| Western blot | Signalling pathway activation | Pathway validation |
Single-cell RNA sequencing
scIVNL-seq resolves in vivo single-cell RNA dynamics of immune cells during Salmonella infection, revealing activation trajectories.
CRISPR knockout and point-mutation screens
Knockout and point-mutation models identify genes and residues required for activation downstream of TLRs and cytokines [1,6].
Autophagy and signalling assays
STING-dependent autophagy assays measure how activation is tuned by degradative pathways.
Neutrophil functional assays
NET formation and proinflammatory cytokine release assays quantify neutrophil activation.
How CRISPR Can Be Used to Study GO:0002263 cell activation involved in immune response
Knockout
CRISPR knockout of TLR adaptors or STAT genes abolishes or reduces activation, providing causal evidence for their role in GO:0002263 [1,6].
Point Mutation
Point mutations in phosphorylation sites of STAT4 or STAT6 can dissect which residues are required for cytokine-driven activation.
Knock-in
Tagged knock-in of STING1 or TLR4 allows real-time tracking of protein localization during activation [1,7].
Overexpression
Overexpression of activating cytokines or signalling kinases can amplify activation phenotypes for gain-of-function studies.
How EDITGENE Supports cell activation involved in immune response Research
Researchers studying cell activation involved in immune response-related genes often need to determine whether a candidate gene is causally involved in activation or merely correlated with it. EDITGENE provides the CRISPR tools and bioinformatics support to make that distinction rigorously.
Contact EDITGENE today to design your custom CRISPR model for cell activation involved in immune response research.
Frequently Asked Questions About cell activation involved in immune response
What is GO:0002263?
GO:0002263 is the Gene Ontology term for cell activation involved in immune response, defined as a change in cell morphology or behavior after exposure to an activating factor that initiates or perpetuates an immune response.
What genes are involved in cell activation involved in immune response?
Key genes include TLR4, MYD88, STING1, STAT4, STAT6, and autophagy genes such as ATG5 and ATG7 [1,6,7].
How is cell activation involved in immune response regulated?
It is regulated by intracellular checkpoints including autophagy and cytokine feedback through STAT4 and STAT6 [6,7].
Which diseases are linked to GO:0002263?
Chronic hepatitis B, hypertension-associated inflammation, autoimmunity, and cancer are linked to dysregulated immune cell activation [2,5,6].
What methods study cell activation involved in immune response?
Single-cell RNA sequencing, CRISPR knockout, point mutation, autophagy flux assays, and cytokine ELISA are commonly used [1,3,7,8].
What is the role of STING in immune cell activation?
STING directly activates autophagy to tune the innate immune response, linking activation to degradative pathways.
How do STAT4 and STAT6 contribute to immune activation?
They drive T helper differentiation and shape cellular and humoral immunity.
Can CRISPR knockout models study GO:0002263?
Yes, knockout of TLR adaptors or STAT genes can abolish or reduce activation, providing causal evidence [1,6].
What is the synonym for GO:0002263?
The synonym is cell activation during immune response.
Why is single-cell RNA sequencing useful for studying immune activation?
It resolves in vivo single-cell RNA dynamics of immune cells during infection, revealing activation trajectories.
Conclusion
GO:0002263 cell activation involved in immune response is a central biological process that converts receptor signals into protective or pathological immune actions [1,2]. Its molecular players, including TLRs, STING, STAT4, and STAT6, are tractable targets for CRISPR-based functional studies [1,6,7]. Understanding this process is essential for developing therapies against infectious, inflammatory, and autoimmune diseases [2,5,6].
References
- 1. Fisch D et al.. 2024. Molecular definition of the endogenous Toll-like receptor signalling pathways.. Nature 631(8021):635-644 PMID: 38961291
- 2. Zheng P et al.. 2023. Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity.. Front Cell Infect Microbiol 13:1206720 PMID: 37424786
- 3. Dömer D et al.. 2021. Neutrophil Extracellular Traps Activate Proinflammatory Functions of Human Neutrophils.. Front Immunol 12:636954 PMID: 34168641
- 4. Ngou BPM et al.. 2021. Mutual potentiation of plant immunity by cell-surface and intracellular receptors.. Nature 592(7852):110-115 PMID: 33692545
- 5. De Sanctis JB. 2022. Innate Immune Response in Hypertension.. Curr Pharm Des 28(36):2984-2990 PMID: 36154596
- 6. Tolomeo M et al.. 2024. STAT4 and STAT6, their role in cellular and humoral immunity and in diverse human diseases.. Int Rev Immunol 43(6):394-418 PMID: 39188021
- 7. Liu D et al.. 2019. STING directly activates autophagy to tune the innate immune response.. Cell Death Differ 26(9):1735-1749 PMID: 30568238
- 8. Xiong Z et al.. 2025. scIVNL-seq resolves in vivo single-cell RNA dynamics of immune cells during Salmonella infection.. Nat Commun 16(1):7937 PMID: 40858611
